June 29 |
|||
| Welcome Fred Saad |
VIEW | ||
| Welcome Naeem Bhojani and Wassim Kassouf |
VIEW | ||
| Welcome Stéphane Bolduc |
VIEW | ||
State-of-the-Art Lecture 1 |
|||
| A doctor's guide to starting a startup Brett Belchetz |
VIEW | ||
State-of-the-Art Lecture 2 |
|||
| AI in healthcare and surgery Frank Rudzicz |
VIEW | ||
CUOG Lecture |
|||
| Reducing errors in science Laurence Klotz |
VIEW | ||
Allied Urology Association Addresses |
|||
| AUA John Lynch |
VIEW | ||
State-of-the-Art Lecture 4 |
|||
| Reducing radiation risk for you and your patient Mitchell Humphreys |
VIEW | ||
Educational Forum 2 |
|||
| How to treat the stones you don't want to treat? Michael Kogon, Mitchell Humphreys and Trevor Schuler |
VIEW | ||
Podium Session 1: Endourology, BPH, Robotics |
|||
| WATER II: AquablatTherapy for Benign Prostatic Hyperplasia (80-150cc) 12 month safety and efficacy results Naeem Bhojani |
VIEW | ||
| Demonstration of an effective ultra- low dose CT protocol with lower radiation dose than abdominal x-ray Kymora Scotland |
VIEW | ||
| Predicting ureteric stone expulsion with patient reported outcomes: a prospective observational study Ryan McLarty |
VIEW | ||
| “Stone-free,” now what? A retrospective review of patients following stone free status Mark Assmus |
VIEW | ||
| Surgical Performance as a Predictor of Functional and Oncological Outcomes in Robotic Prostatectomy Mitchell Goldenberg |
VIEW | ||
| A population-based comparison of healthcare utilization and retreatment after electrode and laser transurethral prostatectomies Blayne Welk |
VIEW | ||
Educational Forum – Clearing the Path: Untangling advanced prostate cancer management |
|||
| Untangling advanced prostate cancer management Kim Chi |
VIEW | ||
| Untangling advanced prostate cancer management Scott North |
VIEW | ||
| Untangling advanced prostate cancer management Fred Saad |
VIEW | ||
State-of-the-Art Lecture 5 |
|||
| Gender confirmation surgery: What every urologist needs to know Richard Santucci |
VIEW | ||
CRPC guidelines |
|||
| CRPC guidelines Fred Saad |
VIEW | ||
June 30 |
|||
| Practice changing studies in GU oncology 2018/2019 Bobby Shayegan |
VIEW | ||
State-of-the-Art Lecture 6 |
|||
| Treating the primary in metastatic prostate cancer: Lessons from the STAMPEDE trial Nicholas James |
VIEW | ||
Educational Forum 3 |
|||
| Case based approach in the management of low volume intermediate risk prostate cancer Joseph Chin, Éric Vigneault and Luke Lavallee |
VIEW | ||
State-of-the-Art Lecture 7 |
|||
| Balancing the risks and benefits of testosterone replacement Ronald Lewis |
VIEW | ||
Urethral stricture guidelines |
|||
| Urethral stricture guidelines Keith F. Rourke |
VIEW | ||
Podium Session 2: Mixed Non-oncology |
|||
| Opioid prescription to patients after low acuity urologic surgery is a risk factor for long-term opioid use Jeffrey Campbell |
VIEW | ||
| Efficacy and safety of mirabegron vs. placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia (PLUS) Sender Herschorn |
VIEW | ||
| Randomized blinded placebo controlled trial of continuous antibiotic prophylaxis for febrile UTI prevention in infants with prenatal hydronephrosis: the alpha study Luis Braga |
VIEW | ||
| Are renal bladder ultrasounds necessary for routine follow-ups of vesicoureteral reflux patients after continuous antibiotic prophylaxis discontinuation? Catherine Anne (Kate) Lovatt |
VIEW | ||
| Comprehensive Prospective Assessment of Patient Reported Outcomes after Urethroplasty Jordan Bekkema |
VIEW | ||
| Implementing and evaluating the efficacy of an Acute Care Urology model of care in a large community hospital Abirami Kirubarajan |
VIEW | ||
Podium Session 3: Prostate Cancer |
|||
| Phase 3 study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): the ARCHES trial Cristiano Ferrario |
VIEW | ||
| A novel predictor of clinical progression in patients on active surveillance for prostate cancer Guan Hee Tan |
VIEW | ||
| Comparison of bone scintigraphy and 18FDG-PET/CT to stage high-grade prostate cancers shows 18FDG-PET/CT has a better accuracy to detect bone metastasis. Samuel Otis-Chapados |
VIEW | ||
| Widespread use of multiparametric MRI in an active surveillance cohort results in earlier identification and treatment of clinically significant prostate cancer Alice Yu |
VIEW | ||
| Comparison of Salvage Prostatectomy versus Salvage Ablative Therapy for Biopsy Proven Radiorecurrent Localized Prostate Cancer. Victor McPherson |
VIEW | ||
| Impact of bone-targeted therapies in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer on enzalutamide: a post hoc analysis of PREVAIL Fred Saad |
VIEW | ||
State-of-the-Art Lecture 8 |
|||
| Navigating female stress incontinence in the era of mesh Kathleen Kobashi |
VIEW | ||
Educational Forum 4 |
|||
| Navigating female stress incontinence in the era of mesh - Common and complex cases in stress urinary incontinence Kathleen Kobashi (PDF), Gary Gray (PDF) and Matthew Andrews (PDF) |
VIEW | ||
CUASF Lecture |
|||
| Management of invasive bladder cancer: The case for integration, regionalization and oncology subspecialization n Armen Aprikian |
VIEW | ||
State-of-the-Art Lecture 9 |
|||
| Medical quackery Joe Schwarcz |
VIEW | ||
July 1 |
|||
| Practice changing studies in benign urology 2018/2019 Shubha De |
VIEW | ||
Podium Session 4: Mixed Oncology |
|||
| TLD-1433 Photodynamic Therapy for BCG-Unresponsive NMIBC – A Phase Ib Clinical Study Girish Kulkarni |
VIEW | ||
| The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy Anna Black |
VIEW | ||
| Statin use and mortality in bladder cancer patients undergoing radical cystectomy in Quebec province, 2000-2014 Armen Aprikian |
VIEW | ||
| IDENTIFY: The Investigation and DEtection of urological Neoplasia in paTIents reFerred with suspected urinarY tract cancer: A multicentre analysis Mark Assmus |
VIEW | ||
| Natural history of renal angiomyolipoma favours surveillance as an initial approach Jake Morris |
VIEW | ||
| Post-nephrectomy upstaging of cT1a to pT3a renal tumor : is renal tumor biopsy a predisposing factor? Charles Asselin |
VIEW | ||
State-of-the-Art Lecture 10 |
|||
| How long term outcomes have changed our approach in the management of patients with spina bifida Mark Cain |
VIEW | ||
Educational Forum 5 |
|||
| Optimizing office management of common pediatric problems Sumit Dave (PDF), Mark Cain (PDF) and Katherine Moore (PDF) |
VIEW | ||
State-of-the-Art Lecture 11 |
|||
| BPH in the elderly, beyond alpha-blockers and 5-ARI Steven Kaplan |
VIEW | ||
Educational Forum 6 |
|||
| Old, anticoagulated and can't pee - Challenging BPH cases Dean Elterman, Steven Kaplan and Mitchell Humphreys |
VIEW | ||
State-of-the-Art Lecture 12 |
|||
| Bladder preservation for muscle invasive disease Nicholas James |
VIEW | ||
Educational Forum 7 |
|||
| Multidisciplinary genitourinary tumor board Nicholas James, Christopher French, Girish Kulkarni and Michael Leveridge |
VIEW | ||
State-of-the-Art Lecture 13 |
|||
| Communicating Science Joe Schwarcz |
VIEW | ||